Superpower is a privately held company tracked for investment-relevant business and technology developments.
| date | round | amount | valuation | investors |
|---|---|---|---|---|
| Jan 2026 | Series A | $40M | not disclosed | not disclosed |
Superpower builds AI-first health platform with 100+ biomarker testing ($199), digital twin, AI clinical reasoning (ensemble models + proprietary clinical canon), and action layer (supplements, pharmaceuticals, peptides). Growing via word-of-mouth with 93% members rating AI report far better than primary care. Planning Series B mid-2025.